Dmitry Balyasny’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-58,448
Closed -$1.43M 3582
2026
Q1
$1.43M Sell
58,448
-55,561
-49% -$1.32M ﹤0.01% 1933
2025
Q4
$2.83M Buy
+114,009
New +$3.03M ﹤0.01% 1702
2025
Q3
Sell
-72,960
Closed -$1.82M 3540
2025
Q2
$1.82M Buy
72,960
+4,051
+6% +$114K ﹤0.01% 1789
2025
Q1
$2.14M Buy
68,909
+59,525
+634% +$1.98M ﹤0.01% 1675
2024
Q4
$296K Sell
9,384
-10,575
-53% -$502K ﹤0.01% 2392
2024
Q3
$1.16M Buy
19,959
+8,532
+75% +$419K ﹤0.01% 1905
2024
Q2
$463K Buy
+11,427
New +$453K ﹤0.01% 2075
2023
Q4
Sell
-13,094
Closed -$404K 2976
2023
Q3
$404K Buy
+13,094
New +$452K ﹤0.01% 1816
2022
Q4
Sell
-43,653
Closed -$1.7M 3306
2022
Q3
$1.7M Buy
43,653
+20,779
+91% +$951K 0.01% 1570
2022
Q2
$883K Sell
22,874
-28,093
-55% -$1.07M ﹤0.01% 1805
2022
Q1
$2.47M Buy
+50,967
New +$2.63M 0.01% 1281
2021
Q4
Sell
-14,040
Closed -$1.28M 2653
2021
Q3
$1.28M Buy
14,040
+7,991
+132% +$680K 0.01% 1269
2021
Q2
$380K Buy
+6,049
New +$224K ﹤0.01% 1603

Other funds holding ASTH

Dmitry Balyasny's ASTH Position: Q2 2026 in Review

Dmitry Balyasny sold out of Astrana Health (ASTH) in Q2 2026, closing a stake of 58,448 shares — an estimated $1.43M sold.

Dmitry Balyasny first reported a position in ASTH in Q2 2021 and held it in 13 quarters. The position peaked at $2.83M in Q4 2025. 207 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Dmitry Balyasny reported no remaining Astrana Health position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 58,448 Astrana Health shares in Q2 2026, an estimated $1.43M.
  • Dmitry Balyasny first reported a position in Astrana Health in Q2 2021 and held it in 13 quarters.
  • Dmitry Balyasny's Astrana Health position peaked at $2.83M in Q4 2025.
  • 207 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.